Tag: AnaptysBio

November 8, 2019

AnaptysBio Reports ATLAS Phase 2b Clinical Trial Fails to Meet Primary Endpoint

AnaptysBio said its Phase 2b clinical trial did not meet its primary endpoint in patients with moderate-to-severe atopic dermatitis.